IL143093A0 - Topical compositions comprising ascomycins - Google Patents

Topical compositions comprising ascomycins

Info

Publication number
IL143093A0
IL143093A0 IL14309399A IL14309399A IL143093A0 IL 143093 A0 IL143093 A0 IL 143093A0 IL 14309399 A IL14309399 A IL 14309399A IL 14309399 A IL14309399 A IL 14309399A IL 143093 A0 IL143093 A0 IL 143093A0
Authority
IL
Israel
Prior art keywords
ascomycins
topical compositions
ascomycin
composition
topical administration
Prior art date
Application number
IL14309399A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL143093A0 publication Critical patent/IL143093A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL14309399A 1998-12-03 1999-12-01 Topical compositions comprising ascomycins IL143093A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9826656.2A GB9826656D0 (en) 1998-12-03 1998-12-03 Organic compounds
PCT/EP1999/009351 WO2000032234A1 (fr) 1998-12-03 1999-12-01 Compositions topiques contenant des ascomycines

Publications (1)

Publication Number Publication Date
IL143093A0 true IL143093A0 (en) 2002-04-21

Family

ID=10843626

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14309399A IL143093A0 (en) 1998-12-03 1999-12-01 Topical compositions comprising ascomycins
IL143093A IL143093A (en) 1998-12-03 2001-05-10 Topical preparations containing ascomycins

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143093A IL143093A (en) 1998-12-03 2001-05-10 Topical preparations containing ascomycins

Country Status (28)

Country Link
US (3) US20010051650A1 (fr)
EP (1) EP1135163B1 (fr)
JP (1) JP3993745B2 (fr)
KR (1) KR100514027B1 (fr)
CN (1) CN1213767C (fr)
AT (1) ATE278422T1 (fr)
AU (1) AU767156B2 (fr)
BR (1) BR9915861A (fr)
CA (1) CA2350884C (fr)
CZ (1) CZ301295B6 (fr)
DE (1) DE69920949T2 (fr)
DK (1) DK1135163T3 (fr)
ES (1) ES2230905T3 (fr)
GB (1) GB9826656D0 (fr)
HK (1) HK1040362A1 (fr)
HU (1) HU228742B1 (fr)
IL (2) IL143093A0 (fr)
NO (1) NO330576B1 (fr)
NZ (1) NZ511687A (fr)
PL (1) PL196628B1 (fr)
PT (1) PT1135163E (fr)
RU (1) RU2234319C2 (fr)
SI (1) SI1135163T1 (fr)
SK (1) SK285811B6 (fr)
TR (1) TR200101547T2 (fr)
TW (1) TWI245640B (fr)
WO (1) WO2000032234A1 (fr)
ZA (1) ZA200104529B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US20030050692A1 (en) * 2000-12-22 2003-03-13 Avantec Vascular Corporation Delivery of therapeutic capable agents
AUPR529701A0 (en) * 2001-05-28 2001-06-21 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US7442391B2 (en) * 2002-01-25 2008-10-28 Integrated Botanical Technologies, Llc Bioactive botanical cosmetic compositions and processes for their production
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
US20060115522A1 (en) * 2003-02-17 2006-06-01 Cipla Ltd Pharmaceutical composition
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
GB0408070D0 (en) * 2004-04-08 2004-05-12 Novartis Ag Pharmaceutical formulations
ES2389443T3 (es) * 2004-04-08 2012-10-26 Meda Pharma S.À.R.L. Composición de espuma de pimecrolimus que contiene hexilenglicol, opcionalmente alcohol de oleílo, dimetilisosorbida y/o triglicéridos de cadena media
US7758901B2 (en) * 2007-02-16 2010-07-20 Betty Bellman Compositions and methods for alleviating skin disorders
DE102008006791B4 (de) * 2008-01-30 2011-11-24 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung
KR101201956B1 (ko) 2009-03-18 2012-11-19 신동헌 파카스트리사민을 유효성분으로 함유하는 과증식성 피부질환과 악성흑색종의 예방 또는 치료용 약학적 조성물
KR102319497B1 (ko) * 2016-03-02 2021-11-01 노반, 인크. 염증 치료용 조성물 및 염증 치료 방법

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5799M (fr) * 1966-03-22 1968-03-25
SE325667B (fr) * 1968-03-06 1970-07-06 Medisan Ab
US4025310A (en) * 1976-05-28 1977-05-24 International Diagnostic Technology, Inc. Method for reading a wet fluorescent surface
DE2714601C2 (de) * 1977-04-01 1984-12-06 Skw Trostberg Ag, 8223 Trostberg Verfahren zur Herstellung eines Harnstoff-Dicyandiamid-Düngemittels
US4324811A (en) * 1980-04-17 1982-04-13 Stauffer Chemical Company Dough-like products exhibiting reduced water activity containing derived protein-containing compositions
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
DE3271532D1 (en) 1981-07-08 1986-07-10 Pfizer Salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
US4401650A (en) * 1981-09-15 1983-08-30 Thiokol Corporation Skin conditioning polymers containing alkoxylated nitrogen salts of sulfonic acid
PH18373A (en) * 1982-02-02 1985-06-13 Unilever Nv Skin treatment composition
JPS6013720A (ja) 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd 生理的活性剤の吸収促進剤
US4488989A (en) * 1983-11-14 1984-12-18 Lever Brothers Company Aqueous compositions containing urea as a hydrotrope
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPS60228423A (ja) 1984-04-26 1985-11-13 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4672078A (en) * 1985-07-03 1987-06-09 Schering-Plough Corporation Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
US4690774A (en) * 1985-09-11 1987-09-01 Chesebrough Pond's Inc. Novel translucent water in oil emulsions
JPH0774144B2 (ja) 1986-03-12 1995-08-09 久光製薬株式会社 尿素を含有する皮膚用組成物
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5385938B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
PH26083A (en) 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
EP0323042A1 (fr) 1987-12-09 1989-07-05 FISONS plc Procédé pour macrolides
CA2000401C (fr) 1988-10-11 1996-05-28 Masato Azuma Preparation pharmaceutique a administration percutanee
US4996193A (en) 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FI104787B (fi) * 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
US5002760A (en) * 1989-10-02 1991-03-26 Katzev Phillip K Retinol skin care composition
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
NZ235991A (en) 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
US5352671A (en) * 1989-11-09 1994-10-04 Sandoz Ltd. Heteroatoms-containing tricyclic compounds
JPH05504956A (ja) 1990-03-12 1993-07-29 藤沢薬品工業株式会社 トリシクロ化合物
JPH05505798A (ja) 1990-03-13 1993-08-26 フアイソンズ・ピーエルシー 免疫抑制マクロ環状化合物
EP0533930A1 (fr) 1990-06-11 1993-03-31 Fujisawa Pharmaceutical Co., Ltd. Utilisation d'un compose de macrolide tel que le fk 506 pour fabriquer un medicament destine a traiter la purpura thrombocytopenique idiopathique et la maladie de basedow
MY110418A (en) 1990-07-02 1998-05-30 Novartis Ag Heteroatoms-containing tricyclic compounds.
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
IE65341B1 (en) 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
JPH04182429A (ja) 1990-11-15 1992-06-30 Fujisawa Pharmaceut Co Ltd 非水溶液製剤
HU208491B (en) 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
US5225403A (en) * 1991-06-25 1993-07-06 Merck & Co., Inc. C-21 hydroxylated FK-506 antagonist
JPH0525046A (ja) 1991-07-18 1993-02-02 Tanabe Seiyaku Co Ltd ニセルゴリン経皮吸収製剤
JPH0543457A (ja) 1991-08-08 1993-02-23 Sekisui Chem Co Ltd 経皮吸収製剤
US5208241A (en) 1991-09-09 1993-05-04 Merck & Co., Inc. N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
US5252732A (en) 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
HUT66531A (en) 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them
DE4234225A1 (de) * 1992-10-10 1994-04-14 Roehm Pharma Gmbh Stabile topische Formulierungen mit gutem Wirkstoff-Freisetzungsvermögen enthaltend mindestens ein lipophilisiertes Makrolidantibiotikum
MY110603A (en) 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
DE4400770C1 (de) 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
JPH07252150A (ja) 1994-03-14 1995-10-03 T T S Gijutsu Kenkyusho:Kk オザグレル含有経皮吸収型製剤
JPH0834731A (ja) 1994-07-26 1996-02-06 T T S Gijutsu Kenkyusho:Kk グラニセトロン含有経皮吸収型製剤
JPH08133979A (ja) 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
KR100434682B1 (ko) * 1994-10-26 2004-08-18 노바티스 아게 약학조성물
IL115742A (en) 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
JPH08143458A (ja) 1994-11-17 1996-06-04 Sekisui Chem Co Ltd 経皮吸収貼付剤
JPH08231369A (ja) 1995-02-20 1996-09-10 Shiseido Co Ltd 化粧料
AR004480A1 (es) 1995-04-06 1998-12-16 Amico Derin C D Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
CZ374797A3 (cs) 1995-05-31 1998-04-15 Schering Ag Farmaceutické preparáty ve formě hydrogelu
AU6900596A (en) 1995-08-24 1997-03-19 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
JP2920611B2 (ja) 1995-12-11 1999-07-19 株式会社シーエーシー 皮膚炎の治療外用剤
DE19549243A1 (de) 1995-12-21 1997-06-26 Schering Ag Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
DE19606355A1 (de) 1996-02-12 1997-08-14 Schering Ag Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung
JPH09315954A (ja) 1996-05-30 1997-12-09 Kita:Kk 眼科手術後の眼組織混濁防止剤。
WO1998009532A1 (fr) * 1996-09-05 1998-03-12 The Pillsbury Company Garnitures aromatisees au fromage et produits alimentaires comprenant ces garnitures
JPH10231248A (ja) 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
JPH10251137A (ja) 1997-03-14 1998-09-22 Advanced Sukin Res Kenkyusho:Kk 光線過敏症抑制剤
GB9713730D0 (en) 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
JP2001520188A (ja) 1997-10-22 2001-10-30 ポニカウ，ジェンス 粘膜組織の炎症を治療および予防するための方法ならびに物質
GB9723669D0 (en) 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6113892A (en) * 1997-12-23 2000-09-05 Helene Curtis, Inc. Compositions for cleansing, conditioning and moisturizing hair and skin
EP0937453A3 (fr) * 1998-01-26 2000-04-19 Sam Schwartz Composition cosmétique, lavante et/ou humidifiante
US5981464A (en) * 1998-01-26 1999-11-09 Lever Brothers Company, Division Of Conopco, Inc. Adjuvant composition
NZ507345A (en) 1998-04-27 2002-12-20 Fujisawa Pharmaceutical Co Medicinal compositions
GB9814640D0 (en) 1998-07-06 1998-09-02 Fujisawa Pharmaceutical Co New use
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth

Also Published As

Publication number Publication date
AU1656900A (en) 2000-06-19
EP1135163B1 (fr) 2004-10-06
DK1135163T3 (da) 2005-01-31
US9402802B2 (en) 2016-08-02
EP1135163A1 (fr) 2001-09-26
HK1040362A1 (en) 2002-06-07
NO20012624D0 (no) 2001-05-29
RU2234319C2 (ru) 2004-08-20
CZ301295B6 (cs) 2010-01-06
WO2000032234A1 (fr) 2000-06-08
HUP0104413A2 (hu) 2002-03-28
SK285811B6 (sk) 2007-08-02
CZ20011908A3 (cs) 2001-09-12
IL143093A (en) 2007-05-15
US20010051650A1 (en) 2001-12-13
TWI245640B (en) 2005-12-21
JP3993745B2 (ja) 2007-10-17
ES2230905T3 (es) 2005-05-01
HUP0104413A3 (en) 2003-12-29
DE69920949D1 (de) 2004-11-11
US20060058279A1 (en) 2006-03-16
CA2350884C (fr) 2007-07-03
HU228742B1 (en) 2013-05-28
BR9915861A (pt) 2001-08-21
PL348750A1 (en) 2002-06-03
US20120202841A1 (en) 2012-08-09
PL196628B1 (pl) 2008-01-31
NZ511687A (en) 2003-10-31
PT1135163E (pt) 2005-02-28
DE69920949T2 (de) 2005-10-13
CN1329507A (zh) 2002-01-02
TR200101547T2 (tr) 2001-10-22
KR100514027B1 (ko) 2005-09-13
ZA200104529B (en) 2002-06-04
JP2002531419A (ja) 2002-09-24
SI1135163T1 (en) 2005-04-30
CN1213767C (zh) 2005-08-10
NO330576B1 (no) 2011-05-16
NO20012624L (no) 2001-07-09
KR20010080663A (ko) 2001-08-22
SK7622001A3 (en) 2001-11-06
AU767156B2 (en) 2003-10-30
CA2350884A1 (fr) 2000-06-08
GB9826656D0 (en) 1999-01-27
ATE278422T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
IL143093A0 (en) Topical compositions comprising ascomycins
CA2338358A1 (fr) Composes permettant de delivrer des agents actifs et compositions a base de ces composes
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
TNSN97010A1 (fr) Cyclopentanopyridyl-oxazolidinones contenant des heteroatomes.
EP1093819A3 (fr) Composés et compositions pour l'administration d'agents actifs
AU4460900A (en) Carrier patch for the delivery of agents to the skin
PL349447A1 (en) Aqueous reactive putties (ii)
AU4710499A (en) Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
ZA9810796B (en) Skin rash prevention composition
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
AU1370000A (en) Oil bodies as topical delivery vehicles for active agents
ZA986720B (en) Photoresponsive sunscreen compositions
IL134592A0 (en) Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects
MY126730A (en) Topical compositions comprising ascomycins
GB2343844A8 (en) Topical therapeutic composition comprising an enzyme
HUP0303486A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anti-arrythmic compounds agents
NZ510584A (en) Methods and compositions for inhibiting neoplastic cell growth
PL347770A1 (en) Composition for the parenteral administration of active agents
IL148234A0 (en) Composition for ivf
HUP0104304A3 (en) Pharmaceutical composition with antitumor activity on the basis of carboplatin
WO2001040241A3 (fr) Derives de ketolide substitues par 6-o-alkyl-2-nor-2-
WO2000011017A3 (fr) Facteurs d'inhibition de synthese et procedes de preparation de ces derniers
MXPA00006072A (es) Metodos y composiciones para inhibir el crecimiento de celulas tumorales.
ZA983243B (en) Novel aryl compounds, processes for their preparation, pharmacological compositions containing the same and their use in therapy.
IT1260498B (it) Composizioni terapeutiche a rilascio ritardato atte ad inibire l'assunzione di oppiacei

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed